Blood pressure medication recall expands for 5th time


A recall of four repackaged lots of blood pressure medicine expanded on Wednesday.

According to the U.S. Food and Drug Administration (FDA), Legacy Pharmaceutical Packaging, LLC has recalled four lots of Losartan Tablet USP 50 mg because of a detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA).

NMBA is a potentially cancer-causing impurity. Losartan Potassium USP is a prescription medication used to treat high blood pressure and congestive heart failure and is packaged in 30ct bottles.

Related: New recalls for high blood pressure medicine that may contain cancer-causing chemical

The four repackaged lots numbers are: 180190, 180191, 181597, 181598. They can be identified on the bottles.

Related: Several recalls issued by the FDA for dry dog food

The company has not received any reports of adverse events related to this recall.

Officials say consumers should contact their physician or healthcare provider if they have questions related to taking this drug.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss